Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Mar 28 04:00PM ET
24.68
Dollar change
-0.84
Percentage change
-3.29
%
Index- P/E- EPS (ttm)-1.86 Insider Own19.07% Shs Outstand55.67M Perf Week2.24%
Market Cap1.37B Forward P/E- EPS next Y-1.61 Insider Trans2.03% Shs Float45.05M Perf Month0.90%
Income-22.58M PEG- EPS next Q-0.73 Inst Own38.41% Short Float6.68% Perf Quarter137.76%
Sales10.19M P/S134.83 EPS this Y73.79% Inst Trans-0.13% Short Ratio4.42 Perf Half Y226.89%
Book/sh0.50 P/B49.57 EPS next Y-13.95% ROA-35.50% Short Interest3.01M Perf Year403.67%
Cash/sh1.63 P/C15.16 EPS next 5Y- ROE-150.60% 52W Range4.44 - 30.96 Perf YTD130.65%
Dividend Est.- P/FCF518.47 EPS past 5Y-42.72% ROI-371.63% 52W High-20.28% Beta1.67
Dividend TTM- Quick Ratio3.96 Sales past 5Y0.00% Gross Margin92.83% 52W Low455.86% ATR (14)1.93
Dividend Ex-Date- Current Ratio3.96 EPS Y/Y TTM39.15% Oper. Margin-222.37% RSI (14)54.70 Volatility7.28% 7.96%
Employees37 Debt/Eq0.04 Sales Y/Y TTM- Profit Margin-221.55% Recom1.00 Target Price32.50
Option/ShortYes / Yes LT Debt/Eq0.00 EPS Q/Q49.39% Payout- Rel Volume1.85 Prev Close25.52
Sales Surprise85.71% EPS Surprise-1440.43% Sales Q/Q- EarningsMar 28 AMC Avg Volume680.96K Price24.68
SMA200.71% SMA5012.93% SMA200116.38% Trades Volume1,257,950 Change-3.29%
Date Action Analyst Rating Change Price Target Change
Jan-29-24Initiated Leerink Partners Outperform $30
Dec-19-23Initiated Wedbush Outperform $12
Oct-29-21Initiated Cantor Fitzgerald Overweight $35
Mar-28-24 11:53PM
04:02PM
Mar-26-24 08:00AM
08:00AM
Mar-18-24 05:44AM
08:00AM Loading…
Mar-07-24 08:00AM
Mar-04-24 07:00AM
Mar-01-24 08:00AM
Feb-20-24 08:15AM
08:00AM
Feb-16-24 04:05PM
Feb-13-24 10:38PM
04:05PM
Feb-07-24 08:34AM
Feb-06-24 09:20AM
08:00AM Loading…
08:00AM
Feb-05-24 08:00AM
Jan-08-24 07:00AM
Jan-04-24 08:00AM
Jan-03-24 08:00AM
Jan-02-24 08:00AM
Dec-26-23 08:30AM
08:30AM
Nov-10-23 08:00AM
Nov-09-23 08:00AM
Nov-08-23 08:00AM
Oct-23-23 02:50AM
Oct-19-23 08:00AM
Oct-04-23 11:00PM
Oct-03-23 08:00AM
08:19PM Loading…
Aug-17-23 08:19PM
Aug-09-23 08:00AM
Jun-30-23 09:51AM
Jun-29-23 09:00AM
Jun-02-23 07:55AM
May-23-23 04:05PM
May-09-23 08:50AM
May-05-23 08:00AM
Apr-20-23 08:50AM
Mar-16-23 08:00AM
Mar-13-23 07:32AM
Mar-09-23 08:45AM
Feb-08-23 08:00AM
Jan-31-23 06:52AM
Jan-06-23 04:05PM
02:46PM
10:35AM
08:00AM
Nov-14-22 08:00AM
Nov-09-22 12:00PM
Oct-04-22 06:08AM
Aug-24-22 06:59AM
Aug-23-22 09:00AM
Aug-05-22 08:00AM
Jul-06-22 09:28AM
08:00AM
Jun-09-22 08:00AM
Jun-02-22 08:00AM
May-26-22 08:07AM
May-23-22 08:00AM
May-19-22 03:27PM
11:31AM
08:00AM
May-12-22 08:00AM
Mar-28-22 08:00AM
Mar-17-22 06:40AM
Mar-14-22 12:30PM
Mar-11-22 10:48AM
08:00AM
Feb-08-22 03:00PM
10:22AM
08:00AM
Jan-11-22 09:56AM
06:46AM
Jan-10-22 04:15PM
Dec-17-21 07:11AM
Dec-07-21 07:00AM
Dec-01-21 01:12PM
07:00AM
Nov-29-21 07:00AM
Nov-15-21 05:00PM
Nov-09-21 04:05PM
Oct-20-21 08:00AM
Oct-18-21 10:01AM
Oct-07-21 09:00AM
Sep-30-21 04:35PM
Sep-22-21 04:05PM
Sep-15-21 04:05PM
Sep-13-21 11:49AM
Sep-07-21 07:00AM
04:52AM
Aug-19-21 04:05PM
02:02PM
Jul-20-21 08:44AM
07:00AM
Jul-06-21 07:00AM
Jun-30-21 07:00AM
Jun-17-21 07:00AM
May-29-21 04:33AM
May-27-21 04:05PM
Immunome, Inc. is a biopharmaceutical company, which engages in the discovery and development of antibody therapeutics products. It also focuses on oncology and infectious disease areas. The company was founded by Scott K. Dessain and Gregory P. Licholai on March 2, 2006 and is headquartered in Exton, PA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
SIEGALL CLAY BPresident and CEOOct 02 '23Buy5.91169,204999,996319,636Oct 04 05:35 PM
Turner BruceChief Strategy OfficerOct 02 '23Buy5.9142,300249,99342,300Oct 04 05:32 PM